CMPX PEER ANALYSIS

Compass Therapeutics Inc. — metric-by-metric comparison with peers and the industry median

CMPXCompass Therapeutics Inc.

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value it Duel

Overall Profile & Returns

· Biotechnology

Position Within Industry

0 = weak quartile, 100 = strong quartile

CMPXIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	CMPX	MSB	TLX	RTALB	Ind. Median
P/E	—	—	—	4.78	18.06
P/B	2.32	—	6.38	0.59●	3.62
EV/EBITDA	—	—	120.20	72.98●	15.13
P/S	—	31.30	3.24●	6.52	10.65

Financial Health
Metric	CMPX	MSB	TLX	RTALB	Ind. Median
Current Ratio	19.04●	—	1.43	1.21	5.90
Debt/Equity	5.3%	—	112.3%	1.2%●	10.9%
NetDebt/EBITDA	2.76	—	13.13	0.90●	1.15

Profitability
Metric	CMPX	MSB	TLX	RTALB	Ind. Median
Net Margin	—	-115.3%	-0.9%	136.3%●	-125.7%
ROE	-45.9%	-11.3%	-1.8%	15.1%●	-47.5%
ROA	-40.5%	-8.6%	-0.7%	13.1%●	-35.8%
EBITDA Margin	—	-76.6%	3.0%	9.0%●	-105.8%

Growth + Dividend
Metric	CMPX	MSB	TLX	RTALB	Ind. Median
Rev. Growth	-100.0%	410.4%●	56.3%	24.0%	5.1%
NI Growth	—	—	—	134.0%	12.1%
Div. Yield	—	0.0%●	—	0.0%●	0.2%
Payout	—	0.0%	—	0.0%	0.0%

Valuation
Metric	CMPX	KROS	APLS	RCKT	PRLD	AVIR	Ind. Median
P/E	—	—	3.22	—	—	—	18.06
P/B	2.32	1.54	1.03●	1.92	6.81	1.65	3.62
EV/EBITDA	—	—	2.77	—	—	—	15.13
P/S	—	13.29	0.39●	—	24.53	—	10.65

Financial Health
Metric	CMPX	KROS	APLS	RCKT	PRLD	AVIR	Ind. Median
Current Ratio	19.04	22.62●	3.63	6.12	2.03	7.89	5.90
Debt/Equity	5.3%	5.7%	114.7%	10.4%	29.4%	0.3%●	10.9%
NetDebt/EBITDA	2.76	2.99	0.38●	0.62	0.84	1.42	1.15

Profitability
Metric	CMPX	KROS	APLS	RCKT	PRLD	AVIR	Ind. Median
Net Margin	—	-256.6%	12.1%●	—	-465.3%	—	-125.7%
ROE	-45.9%	-16.8%	46.0%●	-64.4%	-95.2%	-52.6%	-47.5%
ROA	-40.5%	-15.5%	14.1%●	-55.4%	-59.6%	-48.0%	-35.8%
EBITDA Margin	—	-267.4%	16.3%●	—	-455.3%	—	-105.8%

Growth + Dividend
Metric	CMPX	KROS	APLS	RCKT	PRLD	AVIR	Ind. Median
Rev. Growth	-100.0%	-84.5%	42.5%	-100.0%	138.9%●	-100.0%	5.1%
NI Growth	—	—	—	—	—	—	12.1%
Div. Yield	—	—	—	—	—	—	0.2%
Payout	—	—	—	—	—	—	0.0%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on CMPX

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 7, 26. This content is for informational purposes only and is not investment advice.